| For the Three Months Ended March 31, 2024 | e-Commerce Operations | Healthcare Operations | Eliminations | Total | ||||||||||||
| Pharmacy prescription and other revenue, net of PBM fees | $ | — | $ | 11,324 | $ | — | $ | 11,324 | ||||||||
| e-Commerce revenue | 2,865 | — | — | 2,865 | ||||||||||||
| Pharmacy 340B contract revenue | — | 3,304 | — | 3,304 | ||||||||||||
| Revenues, net | $ | 2,865 | $ | 14,628 | $ | — | $ | 17,493 | ||||||||
| Expenses: | ||||||||||||||||
| Cost of revenue | 2,060 | 10,623 | — | 12,683 | ||||||||||||
| Selling, general and administrative | 1,166 | 899 | (60) | 2,005 | ||||||||||||
| Salaries, wages and payroll taxes | 508 | 2,116 | — | 2,624 | ||||||||||||
| Impairment loss | — | 132 | — | 132 | ||||||||||||
| Professional fees | 507 | 478 | — | 985 | ||||||||||||
| Depreciation and amortization | 130 | 776 | — | 906 | ||||||||||||
| 4,371 | 15,024 | (60) | 19,335 | |||||||||||||
| Loss before other (income) expense | (1,506) | (396) | 60 | (1,842) | ||||||||||||
| Other (expense) income | (203) | (25) | (60) | (168) | ||||||||||||
| Loss before income taxes | (1,303) | (371) | — | (1,674) | ||||||||||||
| Income taxes | (27) | — | — | (27) | ||||||||||||
| Net loss | $ | (1,330) | $ | (371) | $ | — | $ | (1,701) | ||||||||
| e-Commerce Operations | Healthcare Operations | Eliminations | Total | |||||||||||||
| Total assets as of March 31, 2024 | $ | 40,342 | $ | 41,398 | $ | (16,679) | $ | 65,061 | ||||||||
| Total assets as of December 31, 2023 | $ | 40,764 | $ | 40,384 | $ | (16,679) | $ | 64,469 | ||||||||
| e-Commerce Operations | Healthcare Operations | Total | ||||||||||
| Balances as of December 31, 2021 | ||||||||||||
| Goodwill | $ | — | $ | — | $ | — | ||||||
| Accumulated impairment losses | — | — | — | |||||||||
| Goodwill, net as of December 31, 2021 | — | — | — | |||||||||
| Changes in Goodwill during the year ended December 31, 2022: | ||||||||||||
| Goodwill acquired | — | — | — | |||||||||
| Impairment losses | — | — | — | |||||||||
| Balances as of December 31, 2022 | ||||||||||||
| Goodwill | — | — | — | |||||||||
| Accumulated impairment losses | — | — | — | |||||||||
| Goodwill, net as of December 31, 2022 | — | — | — | |||||||||
| Changes in Goodwill during the year ended December 31, 2023: | ||||||||||||
| Goodwill acquired | — | 14,626 | 14,626 | |||||||||
| Impairment losses | — | (13,895) | (13,895) | |||||||||
| Balances as of December 31, 2023 | ||||||||||||
| Goodwill | — | 14,626 | 14,626 | |||||||||
| Accumulated impairment losses | — | (13,895) | (13,895) | |||||||||
| Goodwill, net as of December 31, 2023 | $ | — | $ | 731 | $ | 731 | ||||||
| For the Three Months Ended March 31, 2023 | e-Commerce Operations | Healthcare Operations | Eliminations | Total | ||||||||||||
| Pharmacy prescription and other revenue, net of PBM fees | $ | — | $ | — | $ | — | $ | — | ||||||||
| e-Commerce revenue | 2,876 | — | — | 2,876 | ||||||||||||
| Pharmacy 340B contract revenue | — | — | — | — | ||||||||||||
| Revenues, net | $ | 2,876 | $ | — | $ | — | $ | 2,876 | ||||||||
| Expenses: | ||||||||||||||||
| Cost of revenue | 2,255 | — | — | 2,255 | ||||||||||||
| Selling, general and administrative | 788 | — | — | 788 | ||||||||||||
| Salaries, wages and payroll taxes | 588 | — | — | 588 | ||||||||||||
| Professional fees | 321 | — | — | 321 | ||||||||||||
| Depreciation and amortization | 162 | — | — | 162 | ||||||||||||
| 4,114 | — | — | 4,114 | |||||||||||||
| Loss before other (income) expense | (1,238) | — | — | (1,238) | ||||||||||||
| Other (expense) income | (83) | — | — | (83) | ||||||||||||
| Loss before income taxes | (1,155) | — | — | (1,155) | ||||||||||||
| Income taxes | — | — | — | — | ||||||||||||
| Loss before equity method investment | (1,155) | — | — | (1,155) | ||||||||||||
| Equity in net loss of affiliate | (32) | — | — | (32) | ||||||||||||
| Net loss | $ | (1,187) | $ | — | $ | — | $ | (1,187) | ||||||||
| For the Twelve Months Ended December 31, 2022 | ||||||||||||
| e-Commerce Operations | Healthcare Operations | Total | ||||||||||
| Sales of products, net | ||||||||||||
| Prescription revenue, net of PBM fees | $ | — | $ | — | $ | — | ||||||
| e-Commerce revenue | 11,710 | — | 11,710 | |||||||||
| Subtotal | 11,710 | — | 11,710 | |||||||||
| Revenues from services: | ||||||||||||
| Pharmacy 340B contract revenue | — | — | — | |||||||||
| Revenues, net | $ | 11,710 | $ | — | $ | 11,710 | ||||||
